186 related articles for article (PubMed ID: 19369244)
1. Activated CD11b+ CD15+ granulocytes increase in the blood of patients with uveal melanoma.
McKenna KC; Beatty KM; Bilonick RA; Schoenfield L; Lathrop KL; Singh AD
Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4295-303. PubMed ID: 19369244
[TBL] [Abstract][Full Text] [Related]
2. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
[TBL] [Abstract][Full Text] [Related]
3. Delayed processing of blood increases the frequency of activated CD11b+ CD15+ granulocytes which inhibit T cell function.
McKenna KC; Beatty KM; Vicetti Miguel R; Bilonick RA
J Immunol Methods; 2009 Feb; 341(1-2):68-75. PubMed ID: 19041316
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.
Achberger S; Aldrich W; Tubbs R; Crabb JW; Singh AD; Triozzi PL
Mol Immunol; 2014 Apr; 58(2):182-6. PubMed ID: 24370793
[TBL] [Abstract][Full Text] [Related]
5. CD15+/CD16low human granulocytes from terminal cancer patients: granulocytic myeloid-derived suppressor cells that have suppressive function.
Choi J; Suh B; Ahn YO; Kim TM; Lee JO; Lee SH; Heo DS
Tumour Biol; 2012 Feb; 33(1):121-9. PubMed ID: 22081309
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the CD3zeta chain in T cells infiltrating the synovial membrane of patients with osteoarthritis.
Sakkas LI; Koussidis G; Avgerinos E; Gaughan J; Platsoucas CD
Clin Diagn Lab Immunol; 2004 Jan; 11(1):195-202. PubMed ID: 14715568
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration.
Ly LV; Bronkhorst IH; van Beelen E; Vrolijk J; Taylor AW; Versluis M; Luyten GP; Jager MJ
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5445-51. PubMed ID: 20538984
[TBL] [Abstract][Full Text] [Related]
8. Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
Suesskind D; Ulmer A; Schiebel U; Fierlbeck G; Spitzer B; Spitzer MS; Bartz-Schmidt KU; Grisanti S
Acta Ophthalmol; 2011 Feb; 89(1):17-24. PubMed ID: 21272286
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of putative cancer stem cell markers CD117 and CD15 in choroidal and ciliary body melanoma.
Lukenda A; Dotlic S; Vukojevic N; Saric B; Vranic S; Zarkovic K
J Clin Pathol; 2016 Mar; 69(3):234-9. PubMed ID: 26290260
[TBL] [Abstract][Full Text] [Related]
10. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
11. Myeloid cells obtained from the blood but not from the tumor can suppress T-cell proliferation in patients with melanoma.
Gros A; Turcotte S; Wunderlich JR; Ahmadzadeh M; Dudley ME; Rosenberg SA
Clin Cancer Res; 2012 Oct; 18(19):5212-23. PubMed ID: 22837179
[TBL] [Abstract][Full Text] [Related]
12. PD-L1: PD-1 interaction contributes to the functional suppression of T-cell responses to human uveal melanoma cells in vitro.
Yang W; Chen PW; Li H; Alizadeh H; Niederkorn JY
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2518-25. PubMed ID: 18296654
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
[TBL] [Abstract][Full Text] [Related]
14. Uveal melanoma and pregnancy. A report of 16 cases.
Shields CL; Shields JA; Eagle RC; De Potter P; Menduke H
Ophthalmology; 1991 Nov; 98(11):1667-73. PubMed ID: 1800927
[TBL] [Abstract][Full Text] [Related]
15. Uveal melanomas. Conservation treatment.
Munzenrider JE
Hematol Oncol Clin North Am; 2001 Apr; 15(2):389-402. PubMed ID: 11370500
[TBL] [Abstract][Full Text] [Related]
16. Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells.
Ma J; Usui Y; Takeuchi M; Okunuki Y; Kezuka T; Zhang L; Mizota A; Goto H
Exp Eye Res; 2010 Oct; 91(4):491-9. PubMed ID: 20624388
[TBL] [Abstract][Full Text] [Related]
17. Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer.
Eruslanov E; Neuberger M; Daurkin I; Perrin GQ; Algood C; Dahm P; Rosser C; Vieweg J; Gilbert SM; Kusmartsev S
Int J Cancer; 2012 Mar; 130(5):1109-19. PubMed ID: 21480223
[TBL] [Abstract][Full Text] [Related]
18. HLA Class I and II genotype in uveal melanoma: relation to occurrence and prognosis.
Maat W; Haasnoot GW; Claas FH; Schalij-Delfos NE; Schreuder GM; Jager MJ
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):3-6. PubMed ID: 16384937
[TBL] [Abstract][Full Text] [Related]
19. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of uveal melanoma.
Shields JA; Shields CL; De Potter P; Singh AD
Semin Oncol; 1996 Dec; 23(6):763-7. PubMed ID: 8970600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
